SUDARSHAN PHARMA INDUSTRIES Financial Statement Analysis
|
||
|
The Revenues of SUDARSHAN PHARMA INDUSTRIES have increased by 8.95% YoY .
The Earnings Per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES has increased by 56.45 % YoY. |
||
SUDARSHAN PHARMA INDUSTRIES Last 5 Annual Financial Results
[BOM: 543828]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹505 Cr | ₹464 Cr | ₹461 Cr | ₹357 Cr | ₹193 Cr |
| Expenses | ₹466 Cr | ₹441 Cr | ₹447 Cr | ₹346 Cr | ₹186 Cr |
| Operating Profit (Excl OI) | ₹39 Cr | ₹23 Cr | ₹15 Cr | ₹11 Cr | ₹7.16 Cr |
| Other Income | ₹2.66 Cr | ₹2.61 Cr | ₹1.12 Cr | ₹0.46 Cr | ₹0.38 Cr |
| Interest | ₹16 Cr | ₹8.95 Cr | ₹5.40 Cr | ₹3.38 Cr | ₹3.23 Cr |
| Depreciation | ₹2.81 Cr | ₹1.24 Cr | ₹0.91 Cr | ₹0.87 Cr | ₹0.74 Cr |
| Profit Before Tax | ₹20 Cr | ₹15 Cr | ₹9.50 Cr | ₹7.14 Cr | ₹3.58 Cr |
| Profit After Tax | ₹15 Cr | ₹11 Cr | ₹7.04 Cr | ₹5.25 Cr | ₹2.67 Cr |
| Consolidated Net Profit | ₹15 Cr | ₹11 Cr | ₹7.04 Cr | ₹5.25 Cr | ₹2.67 Cr |
| Earnings Per Share (Rs) | ₹0.97 | ₹0.62 | ₹4.76 | ₹2.92 | ₹5.38 |
| PAT Margin (%) | 3.32 | 2.96 | 2.47 | 1.53 | 1.47 |
| ROE(%) | 16.74 | 12.49 | 10.77 | 10.76 | 20.08 |
| ROCE(%) | 15.18 | 13.90 | 13.75 | 15.25 | 18.67 |
| Total Debt/Equity(x) | 1.87 | 1.33 | 0.94 | 0.34 | 1.03 |
Key Financials |
||
| Market Cap | : | ₹ 852.3 Cr |
| Revenue (TTM) | : | ₹ 780.3 Cr |
| Net Profit(TTM) | : | ₹ 28.9 Cr |
| EPS (TTM) | : | ₹ 1.1 |
| P/E (TTM) | : | 29.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUDARSHAN PHARMA INDUSTRIES | 3.1% | -4.7% | 14.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 8.1% | 9.3% | 9% |
| DIVIS LABORATORIES | 10.5% | 18% | 51.4% |
| TORRENT PHARMACEUTICALS | 2.9% | 2.1% | 30.7% |
| CIPLA | 1.4% | 8.1% | -6.8% |
| DR REDDYS LABORATORIES | -0.1% | 16% | 14.6% |
| MANKIND PHARMA | 4% | 7.5% | 5.8% |
| LUPIN | -0.8% | 2.7% | 0.2% |
| ZYDUS LIFESCIENCES | -3.2% | 7.6% | 21.9% |
SUDARSHAN PHARMA INDUSTRIES Revenues
[BOM: 543828]
| Y-o-Y | 8.95 % |
| 5 Yr CAGR | 27.13 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹505 Cr | 8.95 | |
| Mar2025 | ₹464 Cr | 0.48 | |
| Mar2024 | ₹461 Cr | 29.19 | |
| Mar2023 | ₹357 Cr | 84.69 | |
| Mar2022 | ₹193 Cr | - | |
SUDARSHAN PHARMA INDUSTRIES Operating Profit
[BOM: 543828]
| Y-o-Y | 71.09 % |
| 5 Yr CAGR | 52.78 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹39 Cr | 71.09 | |
| Mar2025 | ₹23 Cr | 55.30 | |
| Mar2024 | ₹15 Cr | 34.56 | |
| Mar2023 | ₹11 Cr | 52.37 | |
| Mar2022 | ₹7.16 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 57.11 % |
| 5 Yr CAGR | 20.14 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 7.73% | 57.11 | |
| Mar2025 | 4.92% | 54.72 | |
| Mar2024 | 3.18% | 3.92 | |
| Mar2023 | 3.06% | -17.52 | |
| Mar2022 | 3.71% | - | |
SUDARSHAN PHARMA INDUSTRIES Profit After Tax
[BOM: 543828]
| Y-o-Y | 30.67 % |
| 5 Yr CAGR | 53.84 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | 30.67 | |
| Mar2025 | ₹11 Cr | 62.78 | |
| Mar2024 | ₹7.04 Cr | 34.09 | |
| Mar2023 | ₹5.25 Cr | 96.41 | |
| Mar2022 | ₹2.67 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 12.16 % |
| 5 Yr CAGR | 22.59 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 3.32 % | 12.16 | |
| Mar2025 | 2.96 % | 19.84 | |
| Mar2024 | 2.47 % | 61.44 | |
| Mar2023 | 1.53 % | 4.08 | |
| Mar2022 | 1.47 % | - | |
SUDARSHAN PHARMA INDUSTRIES Earnings Per Share (EPS)
[BOM: 543828]
| Y-o-Y | 56.45 % |
| 5 Yr CAGR | -34.84 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.97 | 56.45 | |
| Mar2025 | ₹0.62 | -86.97 | |
| Mar2024 | ₹4.76 | 63.01 | |
| Mar2023 | ₹2.92 | -45.72 | |
| Mar2022 | ₹5.38 | - | |
SUDARSHAN PHARMA INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 543828]
| Y-o-Y | 9.21 % |
| 5 Yr CAGR | -5.04 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 15.18% | 9.21 | |
| Mar2025 | 13.9% | 1.09 | |
| Mar2024 | 13.75% | -9.84 | |
| Mar2023 | 15.25% | -18.32 | |
| Mar2022 | 18.67% | - | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Current Share Price | : | ₹33.5 |
| Current MarketCap | : | ₹ 852.3 Cr |
| Updated EOD on | : | Nov 08,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 3.1% |
-4.7% |
14.8% |
| SENSEX | 7% |
11.5% |
-3.5% |
SUDARSHAN PHARMA INDUSTRIES related INDICES
You may also like the below Video Courses
FAQ about SUDARSHAN PHARMA INDUSTRIES Financials
How the annual revenues of SUDARSHAN PHARMA INDUSTRIES have changed ?
The Revenues of SUDARSHAN PHARMA INDUSTRIES have increased by 8.95% YoY .
How the Earnings per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES have changed?
The Earnings Per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES has increased by 56.45 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs